|
Market Closed -
Nasdaq
21:00:00 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 253.40 USD | +1.17% |
|
+3.88% | +43.99% |
| 11-13 | Eisai, Biogen Launch Subcutaneous LEQEMBI Pen in Japan | MT |
| 11-09 | UCB And Biogen Announce Clinical Profile Data For Dapirolizumab Pegol In Systemic Lupus Erythematosus | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.17% | +3.88% | +10.46% | +21.32% | +43.99% | +56.92% | +12.73% | -6.30% | -20.61% | 37.03B | |
| +1.26% | +5.77% | +22.06% | +18.29% | +34.32% | +41.83% | +141.51% | +455.94% | +1,758.50% | 1,271B | |
| +0.79% | +4.93% | +8.35% | +9.54% | +38.08% | +47.00% | +94.06% | +73.17% | +141.20% | 683B | |
| +0.20% | +2.36% | +4.95% | +18.60% | +29.12% | +26.50% | +112.88% | +152.23% | +367.56% | 520B | |
| -0.44% | +3.32% | +12.42% | +10.73% | +23.31% | +39.36% | +70.94% | +9.67% | +72.58% | 389B | |
| +0.55% | +0.56% | +1.59% | +11.16% | +40.38% | +61.57% | +45.73% | +75.90% | +131.06% | 362B | |
| -0.12% | -0.04% | +11.75% | +7.94% | +22.32% | +28.04% | +59.86% | +75.89% | +84.91% | 304B | |
| +0.37% | -0.43% | +16.26% | +19.48% | +1.39% | +3.43% | +38.57% | +58.87% | +223.21% | 286B | |
| -0.30% | +1.17% | +11.52% | +11.89% | +42.27% | +38.48% | +74.21% | +120.29% | +212.45% | 253B | |
| +0.08% | +0.30% | +11.73% | +23.71% | +36.94% | +36.21% | +121.39% | +149.08% | +119.94% | 208B | |
| +0.98% | +2.65% | +8.60% | -7.03% | -14.39% | -13.27% | -59.74% | -24.06% | +143.72% | 180B | |
| +0.21% | -3.31% | +1.73% | +9.81% | +16.02% | +11.67% | -2.00% | -41.91% | -11.35% | 164B | |
| -0.74% | -0.72% | +6.23% | +2.45% | +18.80% | +24.05% | +44.15% | +187.58% | +485.43% | 138B | |
| +1.78% | +0.48% | +10.16% | -0.42% | +17.59% | +29.24% | +25.33% | +6.73% | +12.52% | 127B | |
| +2.39% | +2.87% | +15.39% | +25.50% | +34.44% | +31.17% | +135.00% | +390.51% | +671.03% | 124B | |
| -0.43% | +3.63% | +22.35% | +16.15% | +5.90% | -2.81% | +2.89% | -1.82% | +15.16% | 117B | |
| -3.45% | -7.49% | +4.51% | +250.82% | +657.44% | +736.28% | +218.87% | -3.38% | - | 93.61B | |
| +0.55% | +1.14% | +7.93% | +2.27% | +4.77% | +4.83% | +36.69% | -4.03% | -0.35% | 101B | |
| +0.45% | +5.82% | +25.26% | +19.73% | +23.79% | +40.16% | +19.59% | +51.37% | +127.61% | 95.45B | |
| +0.46% | -0.13% | +19.31% | -0.04% | -12.88% | -8.52% | +53.51% | +74.38% | +553.81% | 73.52B | |
| Average | +0.26% | +1.00% | +11.63% | +23.60% | +53.18% | +61.61% | +62.31% | +90.01% | +267.81% | 276B | |
| Weighted average by Cap. | -0.08% | +2.10% | +12.53% | +17.31% | +37.79% | +44.92% | +84.33% | +165.49% | +551.60% |
- Stock Market
- Stocks
- BIIB Stock
- Sector Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
